Alice K Asher
Biographic Data
| ID | 1736222 |
|---|---|
| NAME | Alice K Asher |
| GIVEN NAMES | Alice K |
| FAMILY NAME | Asher |
| SIGNATURE | ASHER A K |
| AFFILIATIONS | Centers for Disease Control and Prevention |
| VERIFIED | No |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 25 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 2 |
Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs
In this economic evaluation study, based on common benchmarks for cost-effectiveness, frequent HCV testing among PWID was cost-effective in both lower and higher transmission settings
Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services
Background Syringe service programs (SSP) increasingly serve rural areas of the United States, yet little is known about access and perceived need for their services. Objectives: This paper presents the HIV and viral hepatitis prevention, testing, and treatment, and, substance use disorder treatment and overdose prevention services offered at three SSPs and which services their clients accessed. Across the three SSPs, 45 clients (people who injec…
Program Adaptations to Provide Harm Reduction Services During the Covid-19 Pandemic
The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018
Hepatitis C virus (HCV) infection remains an important cause of morbidity and mortality throughout the world, leading to serious health problems among those who are chronically infected. Since 1992, the Centers for Disease Control and Prevention has been collecting data on the incidence of HCV infection in the United States. In 2018, more than 50 000 individuals were estimated to have acute HCV infection. The most recently reported data on the pr…
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
Objectives. To compare US trends in rates of injection drug use (IDU), specifically opioid injection, with national trends in the incidence of acute HCV infection to assess whether these events correlated over time. Methods. We calculated the annual incidence rate and demographic and risk characteristics of reported cases of acute HCV infection using surveillance data from 2004 to 2014 and the annual percentage of admissions to substance use diso…
The impact of social context on self-management in women living with HIV
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
Objectives. To compare US trends in rates of injection drug use (IDU), specifically opioid injection, with national trends in the incidence of acute HCV infection to assess whether these events correlated over time. Methods. We calculated the annual incidence rate and demographic and risk characteristics of reported cases of acute HCV infection using surveillance data from 2004 to 2014 and the annual percentage of admissions to substance use diso…
The impact of social context on self-management in women living with HIV
The impact of social context on self-management in women living with HIV
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
Objectives. To compare US trends in rates of injection drug use (IDU), specifically opioid injection, with national trends in the incidence of acute HCV infection to assess whether these events correlated over time. Methods. We calculated the annual incidence rate and demographic and risk characteristics of reported cases of acute HCV infection using surveillance data from 2004 to 2014 and the annual percentage of admissions to substance use diso…
Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services
Background Syringe service programs (SSP) increasingly serve rural areas of the United States, yet little is known about access and perceived need for their services. Objectives: This paper presents the HIV and viral hepatitis prevention, testing, and treatment, and, substance use disorder treatment and overdose prevention services offered at three SSPs and which services their clients accessed. Across the three SSPs, 45 clients (people who injec…
Program Adaptations to Provide Harm Reduction Services During the Covid-19 Pandemic
The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018
Hepatitis C virus (HCV) infection remains an important cause of morbidity and mortality throughout the world, leading to serious health problems among those who are chronically infected. Since 1992, the Centers for Disease Control and Prevention has been collecting data on the incidence of HCV infection in the United States. In 2018, more than 50 000 individuals were estimated to have acute HCV infection. The most recently reported data on the pr…
Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs
In this economic evaluation study, based on common benchmarks for cost-effectiveness, frequent HCV testing among PWID was cost-effective in both lower and higher transmission settings
HIV, Drug Use, Sexual Risk (6 works) · Medicine (5 works) · Hepatitis C (3 works) · Hepatitis C virus (3 works) · Hepatitis C virus research (3 works) · HIV/AIDS Research and Interventions (3 works) · Nursing (3 works) · Opioid Use Disorder Treatment (3 works) · Public health (3 works) · Virology (3 works)